We studied the effect of intracellular angiotensin II (Ang II) and related peptides on rat aortic contraction, whether this effect is pharmacologically distinguishable from that induced by extracellular stimulation, and determined the Ca 2+ source involved.
SUMMARY 1
We studied the effect of intracellular angiotensin II (Ang II) and related peptides on rat aortic contraction, whether this effect is pharmacologically distinguishable from that induced by extracellular stimulation, and determined the Ca 2+ source involved.
2 Compounds were delivered into the cytoplasm of de-endothelised aorta rings using multilamellar liposomes. Contractions were normalised to the maximum obtained with phenylephrine (10 -5 M). 4 Intracellular administration of CV11947 or PD 123319 right shifted the doseresponse curve about 1000-fold or 20-fold, respectively. PD 123319 was only effective if less than 30 nmol mg -1 Ang II was incorporated.
5 Contraction was partially desensitised to a second intracellular Ang II addition after 45 min (P<0.05).
6 Intracellular administration of Ang I and saralasin also induced contraction (P<0.05). Both responses were sensitive to intracellular CV11947 (P<0.05), but insensitive to PD 123319. The response to Ang I was independent of intracellular captopril.
7 Contraction induced by extracellular application of Ang II and of Ang I was abolished by extracellular pre-treatment with saralasin or CV11947 (P<0.05), but not with PD 123319. Extracellular saralasin induced no contraction.
8 Intracellular Ang II induced contraction was not affected by pre-treatment with heparin filled liposomes, but completely abolished in Ca 2+ -free external medium.
9 These results support the existence of an intracellular binding site for Ang II in rat aorta. Intracellular stimulation induces contraction dependent on Ca
2+
-influx but not on Ins(1,4,5)P 3 mediated release from intracellular Ca 2+ -stores.
Introduction
Since the identification of angiotensin I and angiotensin II (Ang I and Ang II; Skeggs et al., 1956) , the fundamental role of the renin-angiotensin system in the regulation of cardiovascular function is widely accepted. The cellular effects of angiotensin are a consequence of its coupling to specific receptors in the plasma membrane, namely angiotensin (AT) receptors (Timmermans et al., 1993) . Until now, cDNA was cloned for two subtypes, AT 1 and AT 2 , of these receptors, but the existence of possible others subtypes is under investigation (Griendling et al., 1997) . Most of the vascular effects of Ang II are mediated via the AT 1 receptor subtype by activating phospholipase C, and Ins(1,4,5)P 3 and diacylglycerol formation (Griendling et al., 1986; Smith, 1986; Danthluri and Deth, 1986; Murphy et al., 1991) . However, recent studies suggest that Ang II might influence cellular function also from the intracellular side of the plasma membrane (De Mello et al., 1994) . The presence of intracellular Ang II binding sites was described recently in rat cerebellar cortex , and in human placenta, the latter identified as a non-AT 1 /non-AT 2 recognition site (Li et al., 1998) . Intracellular injection of Ang II elicited increases in [Ca 2+ ] i in vascular smooth muscle cells (Haller et al., 1996) and recently we reported a role for intracellular Ang II in signal transduction of an aortic smooth muscle cell line (Filipeanu et al., 1998b) .
Multilamellar liposomes can be directed to and captured in cells, and are subsequently able to transfer their content into the cell. This was shown for smooth muscle cells from rat aorta (Brailoiu et al., 1993; Filipeanu et al., 1998a) , trachea or for the neuromuscular junction (Brailoiu and Van der Kloot 1996) . Besides aqueous signal transduction intermediates, like inositol polyphosphates (Brailoiu et al., 1993; , this type of vesicles is also suitable to deliver other compounds like, peptides and proteins into target cells (Costuleanu et al., 1996; Crommelin et al., 1997) . Therefore, in this paper we use this technique to deliver Ang II or related peptides and AT receptor antagonists into the cytoplasm of rat aortae. The aim of the study was to investigate 1) if these peptides elicit an effect on aortic contraction, and 2) if this effect can be pharmacologically distinguished from that induced by extracellular Ang II or related peptides, and 3) the Ca 2+ source involved in this intracellular induced effect.
Methods

Liposomes preparation
The liposomes used in these physiological studies were prepared from egg phosphatidylcholine, 60 mg lipid per ml of solution to be incorporated, according to the method described by Bangham et al., (1965) as modified by us (Brailoiu et al., 1993) . Control liposomes contained only KCl (140 mM, pH adjusted to 6.9).
The same solution was used to prepare liposomes containing the desired compound. To maximise contractile effects liposomes batches (0.5 ml) were added to the 2-ml organ bath containing 1.5 ml of Krebs-Henseleit buffered solution , with the following composition (mM): NaCl, 118; KCl, 4.8; CaCl 2 , 2.5; MgSO 4 , 1.6; KH 2 PO 4 , 1.2; NaHCO 3 , 25; glucose, 5.5; pH 7.4. In order to remove non-incorporated solutes, liposomes batches were subjected to dialysis (Sigma dialysis tubing, molecular weight cut-off: 12400 dalton) in Krebs-Henseleit buffered solution (150 min, 1 to 600 volume ratio, the buffer being exchanged every 30 min). To control if not incorporated substances were still present in the dialysis buffer, and thereby contributing to the liposomal effects, a similar amount of dialysis buffer was added to control rings in each experiment in a 1 to 4 volume ratio similar to the procedure as used in the liposome experiments. Effects on contraction were never observed.
2.2 Determination of the Ang II concentration delivered into rat aortic smooth muscle cells.
The liposomes were prepared exactly as described in section 2.1, but 
Statistics
The results are expressed as % of the control contraction to 10 -5 M phenylephrine (mean ± SD) or other proper controls when stated. Rings from different animals were used to obtain the number of experiments (n). From one animal a ring was used only once at the desired concentration of (ant)agonist. Statistical significance was tested with unpaired Student t-test or by ANOVA followed by Bonferonni test, P<0.05 being considered significantly different.
RESULTS
Intracellular effects of angiotensin related compounds
The basal tone of the aortic ring was neither modified by control liposomes, containing 140 mM KCl, nor by control dialysis buffer. Complete deendothelisation of the ring was verified by addition of carbachol (10 -5 M) on top of the maximum phenylephrine (10 -5 M) contraction. As shown in the typical tracings (Fig 1) , no relaxation occurred until the washout procedure was started.
In contrast to control liposomes, liposomes filled with 10 -6 M Ang II induced contraction ( Fig 1A) . Extracellular addition of the selective AT 1 receptor antagonist CV11947, the AT 2 receptor antagonist PD 123319 or the non-selective AT receptor antagonist saralasin (all at 10 -6 M) did not influence these contractions (Fig 1B) .
The contractile effect of Ang II filled liposomes was dose dependent (Fig 2) . An of Ang II incorporated into the aorta of less than 30 nmol/mg. A right shift of about 20-fold was obtained for this part of the dose response curve.
The intracellular Ang II induced contractile response is transient (Fig 1) . This might reflect a desensitization process of the receptor comparable to the mechanisms described for extracellular Ang II stimulation (Danthuluri & Deth, 1986; Boulay et al., 1994; Griendling et al., 1997) . Indeed, a washing period of 45 min was not long enough to restore the initial response to a similar dose of intracellular Ang II (Fig 3A) .
Desensitization became already apparent for the lowest amounts of Ang II incorporated intracellularly (P<0.05), but was more prominent if higher amounts were incorporated, reaching a level of about 50 % of the initial contraction for the second response elicited after 45 min (Fig 3B) . Under these circumstances the rings were fully responsive to phenylephrine (data not shown).
The particular properties of the postulated intracellular Ang II receptor become evident from experiments showing that contraction can be induced also by intracellular administered Ang I and saralasin (Fig 4) . In comparison with intracellular Ang II, similar and even stronger contractions were obtained for saralasin (10 -6 M filled liposomes) and Ang I (10 -6 M filled liposomes), respectively. As observed for the Ang II induced contraction, those of Ang I and saralasin were also not affected by pre-treatment with liposomes filled with PD In contrast omission of Ca 2+ from the external medium completely abolished these contractions. Restoring the normal external Ca 2+ concentration by addition of 5 mM CaCl 2 in the continuous presence of Ang II filled liposomes reestablished contraction (Fig 5) .
Discussion
The main objective of this study was to investigate if intracellular Ang II or related peptides affect vascular smooth muscle contraction, and subsequently to characterise this response. We used liposomes to test the effects of intracellular administration of compounds on contraction of de-endothelised rat aorta rings.
We previously demonstrated the effective use of liposomes to study intracellular effects of various compounds in rat aorta (Brailoiu et al., 1993; Filipeanu et al., 1998a) . Integrity of angiotensin containing liposomes is maintained for concentrations less than 10 -5 M Ang I and 10 -4 M Ang II, respectively (Brailoiu et al., 1997) .
Intracellular administration of Ang II induces a dose-dependent contraction. This effect is not due to a non-specific effect of the liposomes, since control liposomes were ineffective. Plasma membrane AT 1 receptor activation is also not involved, in view of the lack of effect of extracellular addition of saralasin, a non-specific AT receptor antagonist and partial agonist of AT receptors (Gavras and Salerno, 1996) , or of extracellular addition of the selective AT 1 receptor antagonist CV11947. Apparently, contraction is stimulated by activation of an intracellular binding site for Ang II. Internalisation of the plasma membrane AT receptor complex after receptor stimulation might contribute to the intracellular pool of receptors and peptides (Anderson et al., 1993; Van Kats et al., 1996) . The binding site observed in our experiments resembles to certain extent the 'normal' plasma membrane AT 1 receptor (Griendling et al., 1997) , but is different in several aspects. Both types of receptors are insensitive to extracellular addition of the AT 2 receptor antagonist PD 123319. The intracellular receptor induced contraction is subjected to a marked dose-dependent desensitization similar to the tachyphylaxis observed after plasma membrane AT receptor stimulation in rat aorta (Danthluri and Deth, 1986) . Both types of receptors are inhibited by CV11947, but the intracellular receptor is only inhibited if this compound is applied from within the cell. The intracellular receptors are also different with respect to the observed sensitivity to intracellular PD 123329.
The related peptides Ang I and saralasin also induce contraction if delivered via liposomes into aortic rings, as tested in a single dose experiment. Both responses are insensitive to intracellular PD 123319, but sensitive to intracellular CV11947.
The response to Ang I was independent of Ang I-converting enzyme activity, since captopril did not affect this response. This might indicate that either 1) intracellular chymase activity or 2) smooth muscle specific neutral metalloendopeptidase activity is present in our preparation (Ferrario et al., 1997), or 3) that these peptides also bind to the active side of the putative intracellular Ang II receptor. However, cleavage of Ang I by chymase activity does not result in Ang II formation in the rat (Yamamoto et al., 1998) , and neutral endopeptidase activity would result in angiotensin -(1-7) that exhibits opposite characteristics than Ang II (Ferrario et al., 1997) . Therefore, the third suggestion is more likely.
Several intracellular binding proteins for angiotensin have been recognised. A protein with high affinity binding for Ang II was purified from rabbit liver (Kiron and Soffer, 1989) . Saralasin bound even more tightly to this protein, while also Ang I was competing for this binding site. More recently subcellular localisation of Ang II immunoreactivity was observed in cerebellar cortex and a non-AT 1 /non-AT 2 binding site was reported within the cytosolic compartment of placenta (Li et al., 1998) . This latter protein resembles the non-AT 1 /non-AT 2 receptor involved in the angiogenesis in chick embryo (Le Noble et al., 1993) . These receptors are insensitive to PD 123319 and the AT 1 receptor antagonist losartan, and at least in the chicken Ang I and [Sar by us has a number of properties in common as described for these binding proteins until now, but seems to be dissimilar from these binding proteins.
The different physiological responses reported on intracellular application of Ang II might be ascribed to stimulation of (one of) these intracellular receptors.
Different aspects of Ca 2+ homeostasis are known to be affected, like Ca 2+ influx in vascular smooth muscle cells (Haller et al., 1996) , gap junction conduction of heart muscle (De Mello, 1994 ) and on 45 Ca 2+ release from permeabilised A7r5 cells (Filipeanu et al., 1998b) . In the present study, contraction was completely abolished in Ca
2+
-free medium, and Ca 2+ mobilisation from Ins(1,4,5)P 3 sensitive Ca 2+ stores appears not to be involved because heparin-filled liposomes failed to affect these contractions, a treatment shown to completely abolish contractions induced by Ins(1,4,5)P 3 in rat aorta (Brailoiu et al., 1993) . Therefore, intracellular
Ang II induced contraction is entirely dependent on Ca 2+ influx from the extracellular medium. Ca 2+ influx is also prominent for the intracellular Ang II induced responses in cultured cells from vascular smooth muscle, but
Ins(1,4,5)P 3 -mediated mechanisms are not excluded (Haller et al., 1996; Filipeanu et al., 1998b) . In contrast to the present results with intracellular stimulation of Ang II, Ca 2+ mobilisation from internal stores plays a major role in extracellular stimulation of vascular smooth muscle with Ang II. Receptor stimulation activates phospholipase C and formation of Ins(1,4,5)P 3 , which subsequently discharges Ca 2+ from internal stores (Alexander et al., 1985; Smith, 1986) , a mechanism directly related to rat aorta contraction (Manolopoulos et al., 1991) . 
